GE Healthcare today unveiled Revolution Ascend with Effortless Workflow, offering clinicians a collection of artificial intelligence technologies that automate...
A Global and Regional Analysis: Focus on Indication and App Type, Case Studies, COVID-19 Impact, and Country-Wise Analysis
London, United Kingdom
Nov 22 - 23, 2021
Pfizer Inc. and BioNTech SE today announced results from a Phase 2/3 trial showing a favorable safety profile and robust neutralizing antibody responses in...
AstraZeneca is planning on establishing a next-generation active pharmaceutical ingredient (API) manufacturing facility for small molecules near Dublin,...
Samsung Bioepis Co., Ltd. and Biogen Inc today announced that the U.S. Food and Drug Administration (FDA) has approved BYOOVIZ (ranibizumab-nuna), a biosimilar...
Novartis Acquires Arctos Medical
AbbVie Submits Regulatory Application to FDA for Risankizumab-rzaa
Abbott Receives FDA Approval for FlexNav TAVR System
Thermo Fisher Scientific Adds Digital PCR to Genetic Analysis Capabilities
Genmab and Seagen Announce FDA Accelerated Approval for TIVDAK
Mercks KEYTRUDA Plus Chemotherapy Reduced Risk of Death by 27%
Grifols Announces its Investment in Biotest
Mercks KEYTRUDA Demonstrated Superior RFS
Complete AAV Production System Enables Scalable Gene Therapy Workflows
Mercks KEYTRUDA Plus Chemotherapy Reduced Risk of Death by One-Third
No more news headlines available